New research suggests that individuals who stop using blockbuster slimming jabs like Mounjaro or Wegovy may regain lost weight at a significantly accelerated pace than those who stop conventional lifestyle plans.
Published data in a prominent medical journal shows that while obese individuals often shed a large proportion of their total mass while on the medication, the mass is regained at an average rate of 0.8 kg per month upon discontinuation.
"Individuals purchasing such medications must be aware of the danger of rapid rebound weight gain when the medication is stopped," cautioned expert Dr. Susan Jebb.
That rate of recovery implies a return to original weight in about a year and a half.
Comparing Therapies
The research, which reviewed dozens of trials involving thousands of participants, contrasted the effects of these new drugs with older methods.
Researchers point out that individuals who shed pounds through diet and exercise typically have a less rapid creep back—perhaps 100 grams monthly—once they finish.
Explaining the Rapid Regain
Nutrition scientists propose the way of the jabs is key to understanding the heightened rebound.
These medications copy a body's own chemical called GLP-1, which moderates hunger.
"Long-term administration of the hormone concentrations several times higher than normal could lead to the body to generate a reduced amount of its endogenous hormone, and may also reduce sensitivity to its actions," explained Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this medication results in appetite is unsuppressed, making binge eating much more probable."
A Lifelong Issue?
Medical guidelines recommend the injections for individuals with obesity-related health risks, alongside prescribed lifestyle changes.
Professionals say that, given the high risk of weight regain, the therapy is often long-term.
This perspective is supported by pharmaceutical companies, who note that the findings "emphasize the chronic character of excess weight," similar to managing conditions like diabetes.
User Accounts
People who have stopped the jabs describe a sudden resurgence of cravings.
"It felt as if something flipping and you become extremely hungry," recalled a patient.
This difficulty is worsened if users have not adopted lasting dietary or behavioural changes during treatment.
Significant Adoption
Figures suggest that millions of adults in the UK have used these injections in the last 12 months, with interest continuing to grow.
- Adoption is more common among females compared to men.
- The middle-aged age group shows the greatest level of interest.
- Many access the medications through private healthcare rather than the NHS.
In conclusion, experts stress that while GLP-1 drugs are potent agents for weight loss, they are not a magic cure and lasting health benefits relies on integrated lifestyle changes.
